Saccular Endovascular Aneurysm Lattice System Interventional Trial
The purpose of this study is to evaluate the safety and effectiveness of an experimental device called the SEAL™ Saccular Endovascular Aneurysm Lattice system, as a possible treatment for certain types of brain aneurysms. This is an experimental procedure and experimental therapy. This means that the procedure and the study device have not been approved by the U.S. Food and Drug Administration (FDA).
Safety and Efficacy of the Alleviant System for No-Implant Interatrial Shunt Creation in Patients with Chronic Heart Failure (ALLAY-HF)
ALLAY-HF is a prospective, multicenter, randomized, sham-controlled, double blinded, adaptive study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFpEF/HFmrEF. Patients will be randomized in a 1:1 ratio to undergo the investigational device procedure or a sham-control procedure. The primary analysis will be performed after all study subjects have the opportunity to complete 12 months of follow-up. Regular follow-up visits are planned to occur through 5 years after the index procedure for all study subjects. Sham-control subjects will be offered an opportunity to cross-over after the 24-month follow-up and undergo the investigational device procedure if they meet study eligibility criteria at that time.
Safety and Efficacy of Topical Bacteriotherapy for Atopic Dermatitis Using Staphylococcus Hominis A9
The study aims to investigate the safety of applying a gel containing a bacteria called S. hominis A9 to the skin on participants with atopic dermatitis. The study will also investigate if S. hominis A9 will work to treat atopic dermatitis. Eligible participants will be asked to put a gel on their skin twice daily for 14 weeks. Half of all study participants will be asked to apply gel with S. hominis A9 bacteria mixed in, and half will be asked to apply a gel without any bacteria mixed in.
Sala Child & Family Support | NYU Langone Health
Hassenfeld Children’s Hospital at NYU Langone provides programs and services that support children and families.
Sala Family Advisory Council | NYU Langone Health
The Sala Family Advisory Council is a partner in advancing Hassenfeld Children’s Hospital’s model of patient- and family-centered care.
Sala Institute delivers family-centered pediatric care | NYU Langone Health
Learn about Sala Institute for Child and Family Centered Care, which helps children feel better when receiving care at NYU Langone.
Sala Institute for Child & Family Centered Care | NYU Langone Health
Sala Institute for Child and Family Centered Care leads support, quality, and safety efforts at Hassenfeld Children’s Hospital at NYU Langone.
Sala Patient & Family Faculty Program | NYU Langone Health
Members of the Sala Patient and Family Faculty Program at Hassenfeld Children’s Hospital at NYU Langone share their care experiences.
Sala Youth Advisory Council | NYU Langone Health
Members of the Sala Youth Advisory Council at Hassenfeld Children’s Hospital at NYU Langone share their experiences of being patients.
Salivary Gland Cancer | NYU Langone Health
Doctors at NYU Langone’s Perlmutter Cancer Center use surgery and radiation therapy—with or without chemotherapy—to manage salivary gland cancer.